The effect of hypocretin replacement therapy in a 3-year-old Weimaraner with narcolepsy.
Animal Medical Center, New York, NY 10021, USA. sjs13@twcny.rr.com
Scott J
SJ
Schatzberg
Katherine
K
Cutter-Schatzberg
Daryl
D
Nydam
Jennifer
J
Barrett
Richard
R
Penn
James
J
Flanders
Alexander
A
deLahunta
Ling
L
Lin
Emmanuel
E
Mignot
D000818:Animals; D002352:Carrier Proteins / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D004283:Dog Diseases / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D004285:Dogs; D007262:Infusions, Intravenous / Q000662:veterinary; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D009290:Narcolepsy / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D009479:Neuropeptides / Q000008:administration & dosage*; D018377:Neurotransmitter Agents / Q000008:administration & dosage*; D000068797:Orexins; D010375:Pedigree; D013566:Sympathomimetics / Q000008:administration & dosage*
D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D000068797:Orexins; D013566:Sympathomimetics